Hackystack
Editorial bloodworkmonitoringeditorial

The bloodwork-shaped hole in peptide-stack discourse

Hackystack ·

Across the 25 public peptide stacks we've analyzed, near-zero authors disclose any bloodwork in their original post. The gap is constant across goals, compounds, and budgets, and worth naming.

Our take
We've analyzed 25 public peptide stacks. We went looking for the one piece of information that would settle most of our open questions about whether these protocols work: bloodwork. Zero of 25 disclosed any. One mentioned nattokinase being good for lipids, but not his lipid panel. This isn't random. The protocols span goals (sleep, body recomp, cognition, longevity) and budgets ($40/mo to $1,800/mo). Some are dialed in, some are sketchy. The bloodwork gap is the constant. A 7-compound body-recomp stack including HGH without disclosed IGF-1 is the same structural problem as a TRT-adjacent cycle without disclosed E2 and hematocrit, and we keep calling it out one stack at a time. The charitable read: labs are private, and the labs people run inform their decisions privately. We believe this for some authors — the experienced operators aren't dosing in the dark. But the post format misleads readers, who can't tell whether a protocol is titrated against numbers or against vibes. The uncharitable read: a lot of this is theater. Quarterly LabCorp panels cost less than two weeks of most of these stacks. If the budget absorbs $300/mo for retatrutide and $200/mo for KLOW but not $80/quarter for IGF-1 and a CMP, the protocol is decorative. We're not asking authors to publish labs. We're asking readers to notice that 'I run this stack' without 'here's what my numbers do' is structurally a fund manager reporting strategy without P&L. The field is louder than it is informed.

What we’re claiming

  • Of 25 public peptide stacks in our corpus, zero authors disclose any bloodwork in their original post.
  • The bloodwork gap is constant across goals, compounds, and budgets — it isn't a niche oversight, it's a discourse default.
  • Quarterly basic labs cost less than two weeks of most of these stacks; the budget excuse doesn't survive contact with the math.
  • Without disclosed numbers, the post format leaves readers unable to distinguish titration-against-data from titration-against-vibes.
  • Our 'highest-value edit' recommendation lands on bloodwork repeatedly because it reliably is the cheapest, highest-value edit available.

Where this argument bends

  • strong Labs are private health information. Not posting them isn't the same as not running them. Several authors in the corpus write with the confidence of operators who almost certainly run quarterly panels and titrate accordingly — they just don't publish IGF-1 trajectories on a social-media account. Demanding public disclosure as a norm would push the most informed authors further out of public discourse, not closer in.
  • moderate Bloodwork-as-proxy-for-rigor is itself a vibe. IGF-1 without symptom tracking, lipids without diet context, hematocrit without hydration state — labs are inputs, not verdicts. A thoughtful subjective protocol with clear symptom endpoints can be more informative than uncontextualized numbers. Treating 'disclosed bloodwork' as the marker of seriousness is a heuristic that flatters quantitative theater.
  • moderate Not every stack needs the same monitoring. Sleep peptide microdoses, topical GHK-Cu, single-compound short cycles, and most supplement-only stacks have a low enough side-effect ceiling that quarterly comprehensive panels would be theater of a different kind. Demanding universal bloodwork conflates a TRT-adjacent body-recomp stack with a 200mcg-before-bed sleep protocol. The bar should scale with the risk surface.
  • minor Twenty-five stacks is a non-random sample. We capture stacks that get traction on social media, which selects for marketing-forward authors. The serious clinicians and researchers running similar protocols may simply not be the ones posting publicly, and the gap we're describing may reflect the sample more than the field. The pattern is still load-bearing for what readers actually encounter — but it's a claim about discourse, not about practice.